Last reviewed · How we verify
NCT06814327: AI4ICU-Obs
Assessment of Organ Failure Risk Predictions in ICU
trial in Circulatory Failure in 499 participants. Participants enrolled and being followed up; not accepting new ones.
15 May 2025
Quick facts
| Lead sponsor | ETH Zurich |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 499 |
| Start date | 18 November 2024 |
| Primary completion | 15 May 2025 |
| Estimated completion | 15 May 2026 |
| Sites | 1 location across Switzerland |
Conditions studied
- Circulatory Failure — all drugs for Circulatory Failure →
- Respiratory Failure — all drugs for Respiratory Failure →
- Renal Failure — all drugs for Renal Failure →
Sponsor
ETH Zurich — full company profile →
Who can join
18 and older, any sex, with Circulatory Failure or Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
During this observational study, the investigators aim to assess the ability of ICU clinicians to predict the risk of impending organ failure and retrospectively compare it to the performance of previously published machine learning models. The central hypothesis of this study is that the treating physician can predict impending organ failure in adult ICU patients with similar accuracy as the best previously publishes machine learning models.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06814327
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Circulatory Failure
Currently open trials in the same condition.
- NCT07522580 — Fluid-responsiveness Assessment Simplified by Electric Cardiometry in Children · recruiting
- NCT06442267 — Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support · Phase 4 · recruiting
- NCT06285331 — the Impact of Manual or Mechanical Ways to Perform PLR on the Accuracy of Evaluation of Fluid Responsiveness · NA · recruiting
Other ETH Zurich trials
Trials by the same sponsor.
- NCT07435766 — Iron Absorption From IFA and MMS Supplements in Kenyan Women During the Second Trimester of Pregnancy · NA · recruiting
- NCT07315295 — Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya · NA · recruiting
- NCT07119411 — ICU Background Early Awareness for Critical deterioratiON · not yet recruiting
- NCT06856291 — Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance · recruiting
- NCT06138990 — Pharmacoscopy-guided Clinical Standard-of-care in r/r AML · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06814327 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ETH Zurich
- Last refreshed: 28 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06814327.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing